In this study blood levels of sP2X7R measured at the time of diagnosis at hospital admission in a cohort of COVID-19 patients were correlated to (a) several markers of inflammation and tissue damage, (b) sNLRP3, IL-6, IL-10, and IL-1β levels, and most importantly, (c) disease progression. This evidence concerns the gene IL6 and COVID-19.